PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,857	6,032	3,383	4,381	2,477	719
Market Cap Growth	55.08%	78.30%	-22.77%	76.88%	244.49%	0.07%
Enterprise Value	4,239	5,449	2,800	4,274	2,462	612
Last Close Price	14.59	18.16	10.21	-	-	-
PE Ratio	44.81	69.04	-	-	-	-
PS Ratio	15.41	21.03	22.44	49.91	118.91	44.34
PB Ratio	6.00	7.45	4.78	11.85	18.37	6.30
P/TBV Ratio	6.05	7.53	4.84	12.08	19.50	6.68
P/FCF Ratio	58.89	121.51	-	-	-	-
P/OCF Ratio	44.66	80.38	-	-	-	-
EV/Sales Ratio	12.74	19.00	18.58	48.69	118.21	37.73
EV/EBITDA Ratio	45.58	100.14	-	-	-	-
EV/EBIT Ratio	51.15	106.51	-	-	-	-
EV/FCF Ratio	51.39	109.75	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.05	0.13	0.13	0.17
Debt / EBITDA Ratio	0.31	0.47	-	-	-	-
Debt / FCF Ratio	0.33	0.57	-	-	-	-
Asset Turnover	0.38	0.33	0.24	0.27	0.11	0.13
Inventory Turnover	0.95	0.86	0.48	0.83	0.60	1.15
Quick Ratio	8.49	9.34	9.86	4.37	2.80	3.37
Current Ratio	9.07	9.94	10.64	5.24	3.49	3.82
Return on Equity (ROE)	14.56%	11.54%	-3.46%	-16.77%	-68.81%	-63.10%
Return on Assets (ROA)	5.86%	3.72%	-5.61%	-11.77%	-30.08%	-25.26%
Return on Capital (ROIC)	6.34%	4.05%	-6.16%	-13.71%	-37.72%	-29.60%
Return on Capital Employed (ROCE)	9.40%	6.10%	-	-	-	-
Earnings Yield	2.23%	1.45%	-0.54%	-0.96%	-3.60%	-7.88%
FCF Yield	1.70%	0.82%	-1.74%	-1.26%	-3.24%	-6.22%
Dividend Yield	-	0.18%	-	-	-	-
Buyback Yield / Dilution	-1.13%	-3.59%	-13.47%	-9.24%	-7.39%	-10.55%
Total Shareholder Return	-1.13%	-3.41%	-13.47%	-9.24%	-7.39%	-10.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.